Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$144.95 - $152.29 $3.94 Million - $4.14 Million
27,215 Added 21.37%
154,585 $23.4 Million
Q2 2022

Jul 27, 2022

BUY
$83.14 - $145.99 $10.6 Million - $18.6 Million
127,370 New
127,370 $18.6 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.56B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Chicago Capital Management, LLC Portfolio

Follow Chicago Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital Management, LLC with notifications on news.